MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 55 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,000 | 0.0% | 5,843 | +8.8% | 0.00% | – |
Q1 2023 | $4,000 | +33.3% | 5,372 | 0.0% | 0.00% | – |
Q4 2022 | $3,000 | -62.5% | 5,372 | -0.2% | 0.00% | – |
Q3 2022 | $8,000 | +60.0% | 5,385 | +24.6% | 0.00% | – |
Q2 2022 | $5,000 | -70.6% | 4,322 | -26.9% | 0.00% | – |
Q1 2022 | $17,000 | -64.6% | 5,910 | -46.2% | 0.00% | – |
Q4 2021 | $48,000 | -2.0% | 10,977 | +64.5% | 0.00% | – |
Q3 2021 | $49,000 | -19.7% | 6,671 | +7.1% | 0.00% | – |
Q2 2021 | $61,000 | +7.0% | 6,229 | +28.0% | 0.00% | – |
Q1 2021 | $57,000 | +137.5% | 4,865 | +64.5% | 0.00% | – |
Q4 2020 | $24,000 | +71.4% | 2,958 | +47.9% | 0.00% | – |
Q3 2020 | $14,000 | -6.7% | 2,000 | 0.0% | 0.00% | – |
Q2 2020 | $15,000 | +15.4% | 2,000 | -3.0% | 0.00% | – |
Q1 2020 | $13,000 | -78.3% | 2,061 | -48.1% | 0.00% | – |
Q4 2019 | $60,000 | +185.7% | 3,972 | +98.6% | 0.00% | – |
Q3 2019 | $21,000 | +10.5% | 2,000 | +54.4% | 0.00% | – |
Q2 2019 | $19,000 | -9.5% | 1,295 | 0.0% | 0.00% | – |
Q1 2019 | $21,000 | +600.0% | 1,295 | +499.5% | 0.00% | – |
Q3 2018 | $3,000 | – | 216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 8,008,204 | $121,404,000 | 75.69% |
Casdin Capital, LLC | 3,098,121 | $46,968,000 | 4.32% |
Alphabet Inc. | 3,339,138 | $50,621,000 | 3.06% |
Eventide Asset Management | 3,393,894 | $51,451,000 | 1.45% |
Opaleye Management Inc. | 449,950 | $6,728,000 | 1.32% |
GILDER GAGNON HOWE & CO LLC | 4,103,425 | $62,208,000 | 0.65% |
HARVARD MANAGEMENT CO INC | 332,610 | $5,042,000 | 0.53% |
Values First Advisors, Inc. | 21,844 | $331,000 | 0.32% |
MYDA Advisors LLC | 22,000 | $334,000 | 0.15% |
Aries Wealth Management | 12,000 | $177,000 | 0.11% |